PEGylation and glycosylation as bioconjugation tools for drug development: New webinar tackles complex chemistry for targeted ...

Vaxcyte, Inc. (NASDAQ:PCVX) is one of the best biotech stocks with high potential. In a report released on October 3, Jason ...

Market, valued at US$136.22 billion in 2024, stood at US$144.20 billion in 2025 and is projected to advance at a resilient ...

Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence Antibody-drug conjugates (ADCs) are ...

Phonons are indeed recognized as vibrations of the lattice that transport heat energy in solids. To contemplate on the idea ...

Pune: Hikal Ltd., the preferred long-term partner for global life sciences companies, has announced the inauguration of its ...

Drug combinations are commonly used in cancer therapy to improve outcomes and mitigate against resistance. This novel approach extends the pre|CISION ® technology to allow for the selective and ...

To explore the latest breakthroughs in proteomics, GEN spoke with five companies at the forefront of proteomic innovation.

Monopar Therapeutics stock has surged 2,000% with ALXN-1840's potential and promising MNPR-101-Zr data. Here's what investors ...

Artificial intelligence (AI) and automation can help reduce administrative burdens in oncology, allowing clinicians to focus more on patient care, says Scott Soefje, PharmD, MBA, BCOP, director of ...

Difluorocarboxyfluorescein NHS Ester, 6-isomer BTQ-1 Amidite (5'-BTQ-1 CE Phosphoramidite) ...